SynthesisMicrobiologyOpen2026
Green-Synthesized Silver Nanoparticles Against Acinetobacter baumannii: A Systematic Review of Antibacterial Activity, Mechanisms of Action, Toxicity, and Antibiofilm Effects.
Synthesis in MicrobiologyOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Acinetobacter baumannii is a major multidrug-resistant nosocomial pathogen, and new antimicrobial strategies are urgently needed. Green-synthesized silver nanoparticles (AgNPs) have emerged as promising candidates because of their broad antibacterial activity and potentially improved biocompatibility. This systematic review evaluated the antibacterial effects of pure, plant-mediated AgNPs against A. baumannii isolates. PubMed, Scopus, and Web of Science were searched from database inception to October 5, 2025 according to PRISMA guidelines. Eligible studies were original English-language reports assessing pure green-synthesized AgNPs against A. baumannii. Sixty-three studies met the inclusion criteria. Green AgNPs were generally active against A. baumannii and more often showed stronger effects than the corresponding plant extracts. The most commonly proposed mechanisms were reactive oxygen species generation, membrane and cell-wall disruption, increased permeability, and damage to proteins, lipids, or DNA. Biofilm data were limited but suggested promising inhibitory potential. Toxicity findings were mixed, ranging from good biocompatibility to cytotoxicity in sensitive cell models. Plant-mediated AgNPs show credible antibacterial potential against A. baumannii, but standardized synthesis, rigorous characterization, biofilm-focused testing, and in vivo safety studies are still needed before clinical translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.